I adskillige kontrollerede studier er det ikke påvist at Epoetin kan forbedre den overordnede overlevelse eller mindske risikoen for tumorprogression hos patienter med cancerrelateret anæmi.
In several controlled studies, epoetins have not been shown to improve overall survival or decrease the risk of tumour progression in patients with anaemia associated with cancer.